Partner Content CDMO insights podcast series: Our Experience is Your Strength | Episode #1 Formulation Spanning topics across R&D, clinical trials, and commercial launch, this new podcast series gets started with a discussion on formulation development, contract services, and some of the critical considerations when moving from molecule to clinic. July 7, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook
Embarking on the journey of drug development is like diving into a sea of possibilities – especially during the exhilarating phase of formulating a potential life-changing medication. The anticipation that follows the discovery of a promising new active pharmaceutical ingredient (API) or combination can be truly electrifying.
In the realm of contract development and manufacturing organizations (CDMO), success hinges on seamless collaboration and meticulous planning. As companies venture into uncharted territories in drug development, it becomes increasingly crucial to navigate these waters with expert guidance.
Devin Corson, Senior Formulation Scientist at Sharp Clinical, sheds light on the intricate process of small molecule formulation development in the inaugural episode of this insightful podcast series. Teaming up with host Steve Jacobs, Devin delves into the nuances of scaling up formulations and underscores the significance of partnering effectively with your CDMO for a smooth transition from laboratory experimentation to clinical application.
“When we’re working with an active pharmaceutical ingredient, there’s so much that is unknown,”
notes Devin Corson.
“We really have no idea how it’s going to affect different parts of the body and how it’s going to interact with different excipients.”
The road to successful clinical trials requires a delicate balance between expediency and thoroughness. While time constraints often loom large over research and development endeavors, dedicating ample time to deciphering an API’s bioavailability, stability, toxicology profile, and compatibility with excipients is paramount.
Sharp’s seasoned scientists bring decades of experience to the table – having conquered numerous obstacles specific to formulation challenges in both small and large molecule drugs. Their wealth of knowledge serves as a beacon for companies navigating the complexities of drug development in collaboration with CDMOs.
This podcast installment marks just the beginning in Sharp’s series titled
“Our experience is your strength.”
Throughout subsequent episodes hosted by Steve Jacobs alongside industry experts in sterile manufacturing, clinical supplies management, commercial packaging solutions, and sustainability practices; listeners are treated to a comprehensive exploration spanning various facets of drug development lifecycles.
As each episode unravels key learnings accumulated over Sharp’s extensive tenure as a CDMO stalwart; audiences are primed for success when engaging their chosen vendor for collaborative endeavors. The insights shared serve as guiding lights illuminating pathways towards optimal outcomes within contract services partnerships.
Navigating through drug development intricacies demands unwavering attention to detail paired with strategic foresight. By leveraging established expertise offered by reputable CDMOs like Sharp Clinical; companies can chart courses towards transformative advancements within pharmaceutical landscapes.
With each episode unveiling layers upon layers of invaluable insights drawn from practical experiences; stakeholders within drug development ecosystems are armed not only with knowledge but also equipped with newfound perspectives aimed at enhancing collaborative engagements across diverse industry segments.
Leave feedback about this